A combined approach integrating personalized nutrition, functional foods, and therapies targeting PPAR isoforms may represent a promising avenue for mitigating obesity-associated postprandial inflammation and long-term cardiometabolic complications. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.